Transaction · 0001971798-26-000005

Wambeke David J.

Wambeke David J., CBO, reported an open-market or private purchase at NEUROONE MEDICAL TECHNOLOGIES Corp involving 33333.000000 shares for an estimated $66999.33. Reported holdings after the transaction were 199999.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCBO
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Filing timeSep 08
Trade dateAug 27, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.62
Pre-filing
1mo ago +3.1%1w ago +32.7%1d ago +30.2%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

NMTC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NMTC since 2026-09-08Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001971798-26-000005
Common Stock
Transaction date
Aug 27, 2026
Filed Sep 08, 2026, 12:31 PM · 12d delay
Shares
33.3k sh
$201 per share
Estimated value
$6.69M
Computed from shares × price
Holdings after
199k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 12 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
+12score
Filing-only score

+12

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staf…

  2. F2

    25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Original filing · 0001971798-26-000005
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NMTC